blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0325063

EP0325063 - Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.01.1995
Database last updated on 25.09.2024
Most recent event   Tooltip12.01.1995No opposition filed within time limitpublished on 01.03.1995 [1995/09]
Applicant(s)For all designated states
MERRELL DOW PHARMACEUTICALS INC.
P.O. Box 156300 2110 East Galbraith Road Cincinnati
Ohio 45215-6300 / US
[N/P]
Former [1989/30]For all designated states
MERRELL DOW PHARMACEUTICALS INC.
P.O. Box 156300 2110 East Galbraith Road
Cincinnati Ohio 45215-6300 / US
Inventor(s)01 / Schechter, Paul J.
20, rue du Général Ducrot
F-67000 Strasbourg / FR
02 / Orwin, John M.
4, Place des Moulins
F-67000 Strasbourg / FR
03 / Hinze, Christian Karl
35, rue Cuvier
F-67000 Strasbourg / FR
[1989/30]
Representative(s)Gillard, Marie-Louise, et al
Cabinet Beau de Loménie 158, rue de l'Université
75340 Paris Cédex 07 / FR
[N/P]
Former [1989/30]Gillard, Marie-Louise, et al
Cabinet Beau de Loménie 158, rue de l'Université
F-75340 Paris Cédex 07 / FR
Application number, filing date88400131.421.01.1988
[1989/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0325063
Date:26.07.1989
Language:EN
[1989/30]
Type: B1 Patent specification 
No.:EP0325063
Date:09.03.1994
Language:EN
[1994/10]
Search report(s)(Supplementary) European search report - dispatched on:EP30.09.1988
ClassificationIPC:A61K31/445
[1989/30]
CPC:
A61K31/445 (EP,KR,US); A61P25/20 (EP); F02D45/00 (KR)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1993/36]
Former [1989/30]AT,  BE,  CH,  DE,  ES,  FR,  GB,  GR,  IT,  LI,  LU,  NL,  SE 
TitleGerman:Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit[1989/30]
English:Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia[1989/30]
French:Utilisation des composés piperidinyliques 1,4-disubstitués pour la manufacture d'un médicament pour le traitement de l'insomnie[1989/30]
Examination procedure10.01.1990Examination requested  [1990/10]
19.09.1990Despatch of a communication from the examining division (Time limit: M06)
27.03.1991Reply to a communication from the examining division
17.10.1991Despatch of communication of intention to grant (Approval: No)
03.02.1993Despatch of a communication from the examining division (Time limit: M02)
05.04.1993Reply to a communication from the examining division
06.06.1993Despatch of communication of intention to grant (Approval: later approval)
21.07.1993Communication of intention to grant the patent
29.10.1993Fee for grant paid
29.10.1993Fee for publishing/printing paid
Opposition(s)10.12.1994No opposition filed within time limit [1995/09]
Fees paidRenewal fee
12.12.1989Renewal fee patent year 03
18.12.1990Renewal fee patent year 04
14.12.1991Renewal fee patent year 05
07.12.1992Renewal fee patent year 06
06.12.1993Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]EP0208235  (MERRELL DOW PHARMA [US])
 [Y]  - BRAIN RESEARCH, vol. 378, no. 1, 16th July 1986, pages 164-168, Elsevier Science Publishers B.V.; C. IDZIKOWSKI et al.: "5-Hydroxytryptamine-2 antagonist increases human slow wave sleep"
 [Y]  - JOURNAL OF THE ROYAL SOCIETY MEDICINE, vol. 80, no. 7, July 1987, pages 409-413, The Royal Society of Medicine; P.A.J. JANSSEN: "Does ritanserin, a potent serotonin-S2 antagonist, restore energetic functions during the night?"
Examination   - Sandrini et al.: "European J. of Pharmacology" 130 (1986), p. 311-314
    - Drug Intelligence and Clinical Pharmacy, vol. 20 (1986), p. 770-775
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.